Cited by 57Pharmacology and Obesity TreatmentCarcinogens and Genotoxicity AssessmentInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen

Garcia, Sérgio Britto, da Costa Barros, Luane Taísa, Turatti, Aline, Martinello, Flávia, Modiano, Patrícia, Ribeiro-Silva, Alfredo, de Oliveira Vespúcio, Marcelo Vinícius, Uyemura, Sérgio Akira·2006·Cancer Letters

Abstract

Orlistat is an anti-obesity agent that increases the fecal fat excretion, which promotes colon carcinogenesis. Therefore, the present study was designed to verify the effects of Orlistat on the formation of rat colonic aberrant crypt foci (ACF) and cell proliferation evaluated by the PCNA method. Male Wistar rats received either a standard diet or a high fat diet (HFD), supplemented or not with Orlistat (200mg/kg chow) and two doses of the carcinogen dimethyl-hydrazine (25mg/Kg). After 30 days, Orlistat was associated to a significant increase in the number of colonic ACFs and cell proliferation in DMH-treated animals, independently of the HFD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2005.09.011

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In animal studies, orlistat was associated with clusters of apoptosis-resistant, neoplastic, and premalignant colonic lesions.

    “In animal studies, orlistat was associated with clusters of apoptosis-resistant, neoplastic, and premalignant colonic lesions [27].”

Citations

Cites

Flagged first, then by citations

1 of the 24 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Metadata

Authors
Garcia, S. B., da Costa Barros, L. T., Turatti, A., Martinello, F., Modiano, P., Ribeiro-Silva, A., de Oliveira Vespúcio, M. V., & Uyemura, S. A.
Affiliations
Universidade de São Paulo (BR)
Corresponding author
Garcia, Sérgio Britto
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2006-08
Volume
240
Issue
2
Pages
221-224
ISSN
0304-3835 (ISSN-L)
OpenAlex
W2060102560
Cited by
57
References
24
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 6 · 2012: 5
FWCI
1.06
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
orlistat, colon carcinogenesis, dimethylhydrazine, high-fat diet, fecal fat excretion, cell proliferation, PCNA, precancerous lesions, anti-obesity drugs
MeSH terms
Orlistat, Animals, Carcinogens, Colonic Neoplasms, Intestinal Mucosa, Lactones, Lipase, Male, Precancerous Conditions, Rats, Wistar, Proliferating Cell Nuclear Antigen, Anti-Obesity Agents, 1,2-Dimethylhydrazine, Cell Proliferation, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review